Stand Up To Cancer - standup2cancer.orgThis is where the end of cancer begins
   Please leave this field empty

Press Releases

Share this:

Like this page on Facebook

CRUK and The Lustgarten Foundation Join With SU2C to Fund New Pancreatic Cancer Dream Team

March 4, 2015— The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Translational Research Grant. The grant provides up to $12 million over a three-year period for research on prevention, diagnosis, or treatment of pancreatic cancer by a “Dream Team” of top scientists.

+ More

SU2C-Lustgarten Foundation Pancreatic Cancer Convergence Dream Team Supports New Immunotherapy Trial

February 26, 2015 - Aduro Biotech, Inc. today announced the initiation of an investigator-sponsored Phase 2 clinical trial of the company’s immuno-oncology product candidates GVAX Pancreas and CRS-207 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab), a monoclonal antibody against programmed death-1 receptor (PD-1).

+ More

Groundbreaking Public Media Project On Cancer Announces TV Special Hosted by Katie Couric

February 4, 2015 -- WETA, the flagship public media station for Washington, D.C., announced today, World Cancer Day, that it has produced a 30-minute television special titled Cancer: The Emperor of All Maladies — A Conversation.

+ More

4 Teams Receive $1M for Research Through SU2C-Phillip A. Sharp Innovation in Collaboration Awards

February 2, 2015 — A total of $1 million has been awarded to four teams of cancer researchers from Stand Up To Cancer (SU2C) to encourage accelerated or elevated collaboration and innovation among SU2C-supported researchers.

+ More

Hollywood Stands Up To Cancer

January 29, 2015 – At last night’s Hollywood Stands Up To Cancer fundraising event, Stand Up To Cancer (SU2C) Co-Founder Katie Couric recognized MasterCard as a SU2C Visionary, a small group of donors who have each contributed more than $25 million. MasterCard then announced its new commitment of $10 million to support SU2C’s innovative cancer research programs.

+ More

Innovate Collaborate Accelerate
Cancer accounts for nearly 1 of every 4 deaths in the US.